Essential Therapeutics is categorized under Primary Care Centers in Birmingham, AL and active since 2010.
Essential Therapeutics was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Rodger Murphree at the company’s single location by writing to 2700 Rogers Drive # 204, Birmingham, Alabama AL 35209 or by phoning (205) 879-2383. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Essential Therapeutics |
Contact Person: | Rodger Murphree |
Address: | 2700 Rogers Drive # 204, Birmingham, Alabama 35209 |
Phone Number: | (205) 879-2383 |
Website Address: | store.drmurphreestore.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Primary Care Centers |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Essential Therapeutics was started in 2010 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Rodger Murphree for inquiries that concern Essential Therapeutics by calling the company number (205) 879-2383, as your correspondence is most welcome. Additionally, the physical location of the single location of Essential Therapeutics can be found at the coordinates 33.481955,-86.786637 as well as the street address 2700 Rogers Drive # 204 in Birmingham, Alabama 35209.
For its online presence, you may visit Essential Therapeutics’s website at store.drmurphreestore.com and engage with its social media outlets through on Twitter and on Facebook.